MannKind (MNKD) Stock Highlights

6.88 | +0.29%

2024-11-21 02:56:38

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Statistics

Range Today

6.8 7.04

Volume Today 1.93M

Range 1 Year

3.17 7.63

Volume 1 Year 662.58M

Range 3 Year

2.49 7.63

Volume 3 Year 2.49B

Range 10 Year

0.67 39.4

Volume 10 Year 7.21B

Highlights

Market Capitalization 2.03B (mid)

Floating Shares 269.61M

Current Price 6.88

Price To Earnings 139

Price To Revenue 7.93

Earnings Per Share 0.05

Payout Ratio 0%

Performance

Latest +0.29%

1 Month +4.72%

3 Months +29.57%

6 Months +49.57%

1 Year +79.63%

3 Years +44.54%

5 Years +488.03%

10 Years -78.02%

Benchmarks

Market Capitalization

127 / 368

Gross Profits

68 / 278

Total Revenue

65 / 300

Total Rank

333 / 368

Free Cashflow

205 / 352

Performance 5 years

18 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.